Literature DB >> 11901835

Molecular techniques in Whipple's disease.

F Fenollar1, D Raoult.   

Abstract

Whipple's disease is a systemic infection, caused by the bacterium Tropheryma whipplei, with protean clinical manifestations characterized by fever, weight loss, diarrhea, polyarthritis, skin hyperpigmentation and adenopathy. For a long time, due to the inability to culture the causative organism, diagnosis was based on histologic examination of infected tissues, usually duodenal biopsies, which revealed diastase-resistant periodic acid-Schiff-positive staining. Now, PCR of various tissues or fluid is emerging as a way to diagnose Whipple's disease. However, the presence of T. whipplei DNA in saliva, gastric juice or duodenal biopsies of healthy individuals has led to questions regarding the specificity of the molecular techniques involved. After a series of failures, stable culture was achieved in 2000. Subsequently, the generation of rabbit polyclonal antibodies has led to the detection of the bacterium in tissues by immunohistology. However, culture and immunohistology are very recent techniques and are not yet widely used. Propagation of the bacterium will lead to extensive molecular knowledge of T. whipplei, which will help in the diagnosis and understanding of the epidemiology and pathogenicity of Whipple's disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11901835     DOI: 10.1586/14737159.1.3.299

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  10 in total

Review 1.  Whipple's disease.

Authors:  Florence Fenollar; Didier Raoult
Journal:  Curr Gastroenterol Rep       Date:  2003-10

2.  Use of shell-vial cell culture assay for isolation of bacteria from clinical specimens: 13 years of experience.

Authors:  Frédérique Gouriet; Florence Fenollar; Jean-Yves Patrice; Michel Drancourt; Didier Raoult
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

3.  Molecular evaluation of antibiotic susceptibility: Tropheryma whipplei paradigm.

Authors:  F Masselot; A Boulos; M Maurin; J M Rolain; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

Review 4.  Clinical Manifestations, Treatment, and Diagnosis of Tropheryma whipplei Infections.

Authors:  Ruben A V Dolmans; C H Edwin Boel; Miangela M Lacle; Johannes G Kusters
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

5.  Use of genome selected repeated sequences increases the sensitivity of PCR detection of Tropheryma whipplei.

Authors:  Florence Fenollar; Pierre-Edouard Fournier; Catherine Robert; Didier Raoult
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

6.  An unusual presentation of Tropheryma whipplei infection.

Authors:  Trace Heavener; Michelle Thompson; Chhaya Patel; Lisa Forrester; Donald Rawls
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-10

7.  Peripheral-blood b-cell subset disturbances in inflammatory joint diseases induced by Tropheryma whipplei.

Authors:  Maëlle Le Goff; Divi Cornec; Dewi Guellec; Thierry Marhadour; Valérie Devauchelle-Pensec; Sandrine Jousse-Joulin; Marion Herbette; Jean Michel Cauvin; Clara Le Guillou; Yves Renaudineau; Christophe Jamin; Jacques Olivier Pers; Alain Saraux
Journal:  PLoS One       Date:  2019-02-27       Impact factor: 3.240

8.  Central nervous system involvement in Whipple disease: clinical study of 18 patients and long-term follow-up.

Authors:  Caroline Compain; Karim Sacre; Xavier Puéchal; Isabelle Klein; Denis Vital-Durand; Jean-Luc Houeto; Thomas De Broucker; Didier Raoult; Thomas Papo
Journal:  Medicine (Baltimore)       Date:  2013-11       Impact factor: 1.889

9.  Constrictive pleuropericarditis: a dominant clinical manifestation in Whipple's disease.

Authors:  George Stojan; Michael T Melia; Sandeep J Khandhar; Peter Illei; Alan N Baer
Journal:  BMC Infect Dis       Date:  2013-12-09       Impact factor: 3.090

10.  Tumoural form of Whipple's disease simulating carcinomatosis.

Authors:  Jamille Hemétrio Salles Martins Costa; Aline Bussinger Maciel; Matheus de Navarro Guimarães Godinho; Rafaela Brito de Paula; Daniel Riani Gotardelo
Journal:  Braz J Infect Dis       Date:  2014-03-29       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.